ANTHEM Q2 : CONS NET PROFIT UP 21.9% AT 211.46 CR (YOY), UP 76.3% (QOQ). STRONG (On 1st Look)

Revenue up 7.9% at ₹594.03 Cr (YOY), up 42.0% (QOQ). Ebitda up 24.1% at ₹330.39 Cr (YOY), up 88.3% (QOQ); margins 55.6% v 48.4% (YOY), 42.0% (QOQ).

Anthem Biosciences Limited